Estimates Revisions Voyager Therapeutics, Inc. Deutsche Boerse AG
Stocks
VT6
US92915B1061
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
08:04:38 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 2.523 EUR | -3.63% |
|
-6.20% | -26.78% |
| 09-11 | Palantir, Voyager-Backed Starlab Seeks ISS Microgravity Research Proposals | MT |
| 09-10 | Voyager Therapeutics, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 03:45 PM |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Voyager Therapeutics, Inc.(VYGR)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Voyager Therapeutics, Inc.(VYGR)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Voyager Therapeutics, Inc.(VYGR)
EBIT
Dividend / Share (DPS)
Data source:
Voyager Therapeutics, Inc.(VYGR)
Cash or Net Debt
- Stock Market
- Stocks
- VYGR Stock
- VT6 Stock
- Consensus Voyager Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
